New tentative approval for Gilead Sciences drug sofosbuvir
[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in […]
New tentative approval for Gilead Sciences drug sofosbuvir Read Post »